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( p = 0.035). The cytology tests of the samples obtained via 
self-collection were sensitive and had a positive predictive 
value and an area under the curve (AUC) that were signifi-
cantly lower than those of the Pap test. However, the speci-
ficity and negative predictive value of these tests were simi-
lar. When compared with the HPV test, the self-collected 
samples demonstrated lower accuracy in predicting high-
grade cervical intraepithelial neoplasia or worse, with a sig-
nificantly lower sensitivity, positive predictive value, and 
AUC than the cervical Pap test samples.  Conclusion: Self-col-
lection by vaginal lavage is simple and well accepted by 
women. Due to its limitations, however, self-collection by la-
vage should be utilized with caution.  © 2017 S. Karger AG, Basel 
 Introduction 
 Cervical cancer is a major public health problem, being 
the third leading cancer in women worldwide, following 
only breast and colorectal cancer. Approximately 500,000 
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 Abstract 
 Objective: To compare the results of cervical cytology and 
high-risk HPV tests using samples obtained using two differ-
ent collection modalities in a population of Brazilian women: 
self-collection (vaginal lavage) and cervical Pap testing. 
 Methods: We enrolled 204 women who were aged 18–64 
years and had previously obtained abnormal cervical cytol-
ogy test results; 83.8% of them agreed to participate. The 
sample was divided into two aliquots: one for the cytological 
study and one for the molecular analysis of high-risk HPV. 
 Results: Fifty-eight percent of the participants preferred to 
utilize self-collection as an alternative screening method. 
However, we noticed that the HPV positivity rate was sig-
nificantly lower in self-collected samples when compared to 
those obtained using the conventional collection method
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new cases and 280,000 deaths occur due to cervical cancer 
annually worldwide  [1, 2] .
 High-risk HPV DNA testing is more sensitive than cy-
tology in detecting precancerous lesions, as one of the 
main advantages of its use is the prolonged tracking pe-
riod, even if this requires organized screening programs 
with strict protocols, monitoring, and tracing  [3] . Self-
collection should be offered as an option to women, espe-
cially those facing barriers to screening. Self-collection of 
cervicovaginal material via lavage may serve as a good 
tool to facilitate women’s participation in cervical cancer 
screening programs  [4] .
 In Brazil, cervical cancer remains a major public health 
issue, causing significant morbidity and mortality among 
women  [5] . In spite of the government’s efforts to reduce 
the rates of cervical cancer incidence and mortality in 
Brazil, the results of the screening program, which was 
based on cervical cytology, remain disappointing. Novel 
mechanisms by which to explore cervical cancer screen-
ing are necessary for a more effective control of this dis-
ease in the Brazilian setting.
 The goal of this study was to compare the results of 
cervical cytology and high-risk HPV testing on samples 
obtained using two different collection methods in a 
population of Brazilian women: self-collection (vaginal 
lavage) and conventional collection (Pap test) by a doc-
tor.
 Subjects and Methods 
 The study included women aged 18–64 years who were referred 
to the Colposcopy Ambulatory of the Prevention Department at 
Barretos Cancer Hospital (Brazil) due to abnormal (atypical squa-
mous cells of uncertain significance or worse) cervical cytology test 
results (Pap smear) from April 2013 to March 2014.
 Once adequately informed about the study, the women re-
ceived a syringe containing 20 mL of 0.9% sodium chloride solu-
tion that was attached to a urethral catheter No. 18. The women 
were instructed to lie comfortably on a stretcher and gently intro-
duce the urethral probe approximately 10 cm or as deep as possible 
into the vagina and inject all of the saline solution (self-collection). 
Immediately after infusion of the saline solution, the women aspi-
rated the fluid into the syringe. The recovered fluid (average vol-
ume 10 mL) was then transferred to an ethanol-based liquid me-
dium for preservation and transport (SurePath; Becton, Dickinson 
and Company, Research Triangle Park, NC, USA).  Figure 1 shows 
the materials used to perform the lavage.
 When this step was completed, the women underwent gyneco-
logic and colposcopy examinations (in the same room), which 
were performed by the attending physician. Prior to colposcopy, 
the medical doctor collected cervical material from the cervix 
(standard collection), sampled the ecto- and endocervix with a 
specific brush indicated for this purpose (Rovers; Rovers Medical 
Devices, Oss, The Netherlands), and transferred the material to a 
second flask containing an ethanol-based liquid medium (Sure-
Path). When the collection was completed, colposcopy and biopsy 
of the cervix were performed whenever indicated.
 When the colposcopy examination was completed, the women 
replied to a questionnaire about their acceptance of the self-collec-
tion procedure (vaginal lavage). Illiterate women were interviewed 
by two study coordinators trained and experienced in the admin-
istration of medical surveys. The researcher wrote down the results 
of the colposcopy examinations, cytological examination, hybrid 
capture, and histopathology (when the biopsy was considered nec-
essary) for each woman on dedicated forms.
 Figure 2 summarizes the distribution of the cases according to 
the collected material and tests performed. Overall, 204 women 
were recruited into this study, of whom 171 (83.8%) agreed to par-
ticipate and signed the informed consent form. The main reasons 
for refusal were as follows: the procedure was considered difficult 
(27%); pain (21%); they preferred that the physician did the pro-
cedure (9%); fear/anxiety (6%); shame/embarrassment (3%); and 
other (34%). Of the participants, 30 were unable to perform the 
self-collection.
 The samples were forwarded to the Pathological Anatomy Lab-
oratory at Barretos Cancer Hospital for proper processing and 
reading. They were divided into two aliquots: one for the cytolog-
ical study and another for the molecular analysis of high-risk HPV. 
The preparation of slides for cytology, as well as coloring, was com-
pleted in an automated fashion with the PrepMate TM /PrepStain TM 
system (Becton, Dickinson and Company) according to the proto-
cols of the hospital’s pathology department and the manufacturer’s 
recommendations. Reading of the slides was performed manually 
by a single blinded cytotechnologist employed at the pathology 
department and experienced in such readings who did not have 
knowledge of the type of collection being carried out. Ten percent 
of the negatives and all positives were reviewed by a single expert 
pathologist (C.S.-N.).
 High-risk HPV testing was carried out using the Hybrid Cap-
ture 2 TM test (Qiagen, Hilden, Germany). The test was performed 
according to the manufacturer’s guidelines. 
 Fig. 1. The materials used to carry out the lavage: a syringe filled 
with 20 mL of 0.9% saline solution and a urethral probe. 
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Accepted to participate
in the study: 171
Invited to participate
in the study: 204
Candidates for
self-collection: 171
Candidates for
cervical cytology: 171
Refused: 33
Performed
collection: 141
Performed
cytology: 141
Performed
HPV test: 136a
Unable to perform
self-collection: 30
Performed
collection: 163
Performed
cytology: 163
Performed
HPV test: 151b
Material not
collected: 8
 Fig. 2. Distribution of cases according to collected material and tests performed.  a  Five tests were not performed 
due to insufficient material.  b  Twelve tests were not performed due to insufficient material. 
 Table 1.  Characteristics of the study population according to sociodemographic factors, sexual habits, reproduc-
tive history, and colposcopy and cervical biopsy results (n = 163)
Variable Category Subjects, n (%) Average (SD)
Age <25 years 19 (11.7)
25 – 45 years 83 (50.9)
46 – 64 years 61 (37.4)
Educational level No schooling (illiterate) 6 (3.7)
Elementary school 78 (47.9)
High school 62 (38.0)
Higher education 17 (10.4)
Age at first intercourse, years – – 17.3 (3.2)
Number of sex partners (n = 159) – – 3.5 (4.5)
Number of children – – 2.3 (1.6)
Cervical biopsy No lesion 35 (36.5)
CIN 1 27 (28.1)
CIN 2/3 25 (26.0)
Adenocarcinoma in situ 1 (1.0)
Invasive carcinoma 2 (2.1)
Insufficient material 3 (3.1)
Other 3 (3.1)
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 Statistical Analysis 
 The results of the tests were examined using descriptive statistics. 
The McNemar test was used to compare percentages between paired 
groups. Concordance between the cytology results and the HPV test 
results was evaluated by the kappa statistic. The efficacy of both col-
lection mechanisms in predicting the presence of precursor/invasive 
lesions of the cervix was measured by determining their sensitivity, 
specificity, and predictive values (negative and positive).
 For these calculations, cervical biopsy or conization products 
were considered as the gold standard for examinations. Cases with 
cervical biopsies that indicated the presence of high-grade cervical 
intraepithelial neoplasia or worse (CIN 2+) were considered posi-
tive. Cases with adequate colposcopy and an absence of findings that 
warranted biopsy of the cervix were classified as negative. The re-
spective accuracy indicators and their corresponding 95% confi-
dence intervals (sensitivity, specificity, positive predictive value, 
negative predictive value, and area under the curve [AUC]) as well 
as the concordance value were calculated so that the collection 
methods could be compared. For sample size calculation, the follow-
ing assumptions were made: (1) a sensitivity of 65% and a specific-
ity of 85% for cervical cytology examinations performed using wa-
ter; (2) an accuracy of 0.15; (3) an α error of 5%; (4) an estimated 
prevalence of cervical disease of 30% in an outpatient high-risk pop-
ulation (colposcopy ambulatory); and (5) a loss of 1.0% (poor or 
missing material). Thus, the estimated sample size was approxi-
mately 150 women.
 Results 
 Table  1 summarizes the characteristics of the study 
population. Most women were older than 25 years, were 
married or cohabiting with a partner, were white, had a 
low level of education, and had a low family income (less 
than BRL 1,000 a month [approx. USD 300]; data on mar-
ital status, race, and family income are not shown in  Ta-
ble 1 ). On average, the women became sexually active at 
the age of 17 years, had 2 children, and had a history of 3 
sexual partners over their lifetime. All women underwent 
colposcopy, and in 23.3% of the cases, the squamocolum-
nar junction was not fully visible ( n = 38). Colposcopic 
abnormalities were found in 74 of 125 women (59.2%) in 
whom the squamocolumnar junction was fully visible.
 Table 2 shows the numbers and percentages of women 
providing affirmative answers to the questions on accep-
tance regarding the self-collection method. The respons-
es to the first 4 questions showed that most participants 
had no problem with understanding and performing the 
procedure, and that they managed to insert the probe and 
inject the liquid. Most participants thought the method 
was easy to perform and not uncomfortable or embar-
rassing. Fifty-eight percent of the participants reported 
preferring to use self-collection as an alternative screen-
ing method.
 Table 3 describes the results of the cervical cytology 
examination, the glandular representation, and the result 
of the HPV test (hybrid capture) according to the method 
of collection utilized.
 Table 4 shows the comparison between the results of 
cervical cytology and HPV testing according to the meth-
od of collection used. The glandular representation rate 
was significantly higher when the standard collection 
method was used than with the self-collection method
( p < 0.001). High-grade squamous intraepithelial lesions 
were diagnosed more frequently when the conventional 
collection method was used. We also observed that the 
 Table 2.  Numbers and percentages of cases according to their re-
sponses to the acceptance questionnaire assessing sample collec-
tion via vaginal lavage
Question Answer n (%)
Did you have trouble 
understanding how to carry 
out the exam?
No 143 (89.4)
A little 13 (8.1)
Moderately/a lot 4 (2.6)
Was it difficult to carry out 
the procedure lying down 
on the stretcher?
No 136 (85.0)
A little 15 (9.4)
Moderately/a lot 9 (5.7)
Were there any difficulties 
when inserting the probe 
into the vagina?
No 138 (86.3)
A little 13 (8.1)
Moderately/a lot 9 (5.7)
Was there any difficulty 
when injecting the liquid 
into the vagina?
No 143 (86.3)
A little 13 (8.1)
Moderately/a lot 4 (5.7)
Was there any discomfort 
when aspirating the liquid 
injected into the vagina?
No 90 (56.3)
A little 39 (24.4)
Moderately/a lot 31 (19.4)
Did the liquid you injected 
trickle out of the vagina?
No 23 (14.4)
A little 46 (28.8)
Moderately/a lot 90 (56.4)
Was it easy to use this 
method of collection?
Easy 112 (70.0)
A little difficult 22 (13.8)
Moderately/very difficult 26 (16.3)
Do you think this collection 
method caused any 
embarrassment or shame?
No 149 (93.7)
A little 7 (4.4)
Moderately/a lot 3 (1.9)
Did you find that this 
collection method was 
uncomfortable?
No 142 (88.8)
A little 15 (9.4)
Moderately/a lot 3 (1.9)
Which collection method 
do you prefer?
Self-collection 94 (58.8)
Health professional 46 (28.8)
It doesn’t matter 19 (11.9)
I don’t know 1 (0.6)
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 Table 3.  Distribution of cases according to the results of their cervical cytology examination and HPV testing and 
the type of collection used
Variable Category Self-collection
(n = 141), n (%)
Conventional collection 
(n = 163), n (%)
Result of the cytology examination No change 97 (68.8) 107 (65.6)
ASC-US 14 (9.9) 12 (7.4)
ASC-H 2 (1.4) 3 (1.8)
LSIL 14 (9.9) 18 (11.0)
HSIL 1 (0.7) 15 (9.2)
Invasive 1 (0.7) 1 (0.6)
Adenocarcinoma in situ 0 (0.0) 1 (0.6)
Unsatisfactory 12 (8.5) 6 (3.7)
Glandular representation No 116 (82.3) 27 (16.6)
Yes 12 (8.5) 129 (79.1)
Unsatisfactory 13 (9.2) 7 (4.3)
HPV test (hybrid capture) Negative 95 (69.9) 94 (62.3)
Positive 41 (30.1) 57 (37.7)
ASC-US, atypical squamous cells of uncertain significance; ASC-H, atypical squamous cells not excluding 
high-grade lesions; LSIL, low-grade squamous intraepithelial lesion; HSIL, high-grade squamous intraepithelial 
lesion.
 Table 4.  Comparison of results of the cytological examination and HPV testing according to the type of collec-
tion used
Examination result Category Self-collection, 
n (%)
Conventional 
collection, n (%)
p value1
Unsatisfactory cytology No 129 (91.5) 136 (96.5) 0.118
Yes 12 (8.5) 5 (3.5)
Glandular representation No 129 (91.5) 29 (20.6) <0.001
Yes 12 (8.5) 112 (79.4)
ASC-US+ No 94 (75.2) 86 (68.8) 0.291
Yes 31 (24.8) 39 (31.2)
ASC-H+ No 108 (86.4) 96 (76.8) 0.036
Yes 17 (13.6) 29 (23.2)
LSIL+ No 110 (88.0) 98 (78.4) 0.029
Yes 15 (12.0) 27 (21.6)
HSIL+ No 123 (98.4) 115 (92.0) 0.008
Yes 2 (1.6) 10 (8.0)
HPV test (hybrid capture) Negative 90 (70.9) 77 (75.5) 0.035
Positive 37 (29.1) 50 (39.4)
 Bold type denotes significance. ASC-US, atypical squamous cells of uncertain significance; ASC-H, atypical 
squamous cells not excluding high-grade lesions; LSIL, low-grade squamous intraepithelial lesion; HSIL, high-
grade squamous intraepithelial lesion. 1 McNemar test.
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rate of HPV positivity was significantly lower in self-col-
lected samples than in samples collected conventionally 
( p = 0.035). We observed a low reproducibility in the 
HPV tests of the self-collected samples (κ = 0.43; 95% CI: 
0.27–0.59).
 Table 5 provides the results for the analysis of the ac-
curacy in predicting CIN 2+ according to different diag-
nostic criteria. Cytology obtained by self-collection dem-
onstrated a sensitivity, positive predictive value, and AUC 
that were significantly lower than those of standard col-
lection. However, the specificity and negative predictive 
value were similar for both tests. In comparison with the 
HPV test, self-collected samples showed lower accuracy 
in predicting CIN 2+, with a significantly lower sensitiv-
ity, positive predictive value, and AUC than with stan-
dard collection.
 Discussion 
 According to data from the Brazilian National House-
hold Sample Survey (PNAD), the Pap smear examination 
coverage rate in Brazil should be greater than 80%  [6] . 
However, when performing a historical analysis of the 
nearly 81 million Pap tests collected in Brazil from 2006 
to 2013, Costa et al.  [7] concluded that, in fact, the Pap 
test coverage was much lower than that reported by the 
PNAD, especially in the public system that accounted for 
a large proportion of Pap tests performed on women of 
the population targeted for screening (between 25 and 64 
years old); considering that many women in the target 
screening population underwent Pap tests and that wom-
en usually underwent Pap tests twice a year, one can pre-
sume that 80% is unrealistic  [7] . This shows the need to 
innovate and design new screening programs for cervical 
cancer in Brazil in order to improve Pap test coverage 
rates.
 In the Brazilian setting, self-collection could be an at-
tractive alternative for populations having poor access to 
health facilities, such as riverine communities in the Am-
azon region or remote rural areas. Many women who cur-
rently do not have Pap tests done at health care facilities 
due to embarrassment or because of being distant from 
the collection sites would be included in the national 
screening program if they were able to self-collect cervi-
covaginal material. However, a limitation of self-collec-
tion is that the cytology examination is poor and not ap-
plicable to screening. All analyses of this material should 
be done via molecular testing. Hence, the Brazilian public 
health system would need to be ready to perform molecu-
lar tests for large-scale HPV DNA detection if a self-col-
lection approach were adopted. Nevertheless, according 
to the Brazilian Guidelines for Screening of Cervical Can-
cer, published by the Health Ministry in 2011, HPV test-
ing is not yet recommended as a screening tool in Brazil 
 [5] .
 Several studies have shown that self-collection is well 
accepted by most women, being an attractive alternative 
strategy for cervical cancer screening, especially in hard-
to-reach and remote areas  [8–15] . In Brazil, a limited 
 Table 5.  Analysis of the accuracy of diagnosing ASC-US+ according to cytology and HPV testing results
Collection method Statistic  Statistical criterion used for the diagnosis of CIN 2+
cytol ogy (ASC-H+) HPV (+)
Self-collection Sensitivity, % 33.3 (13.3 – 59.0) 50.0 (27.2 – 72.8)
Specificity, % 87.6 (79.0 – 93.7) 71.7 (61.4 – 80.6)
Positive predictive value, % 35.3 (13.7 – 62.5) 27.8 (14.2 – 45.2)
Negative predictive value, % 86.7 (77.9 – 92.9) 86.8 (77.1 – 93.5)
AUC 0.61 (0.45 – 0.76) 0.61 (0.47 – 0.75)
Conventional 
collection
(standard)
Sensitivity, % 71.4 (51.3 – 86.8) 81.5 (61.2 – 93.7)
Specificity, % 86.9 (78.6 – 92.8) 71.3 (61.0 – 80.1)
Positive predictive value, % 60.6 (41.8 – 77.3) 44.9 (30.7 – 59.8)
Negative predictive value, % 91.5 (83.9 – 96.3) 93.1 (84.5 – 97.7)
AUC 0.79 (0.69 – 0.90) 0.76 (0.66 – 0.87)
Values in parentheses denote 95% CI. AUC, area under the curve; ASC-US, atypical squamous cells of uncer-
tain significance; ASC-H, atypical squamous cells not excluding high-grade lesions; CIN 2+, high-grade cervical 
intraepithelial neoplasia or worse.
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number of publications have evaluated self-collection as 
an alternative method  [16–18] . A study conducted by Lo-
renzi et al.  [19] included 2,000 randomly selected female 
candidates for screening of cervical cancer and divided 
them into two groups: one group carried out self-collec-
tion using a tapered brush inserted into the vagina, the 
other group underwent conventional collection per-
formed by a health professional, using a brush and spat-
ula. Using a modified hybrid capture test, careHPV (Qia-
gen Inc., Gaithersburg, MD, USA), the prevalence of 
high-risk HPV infection was evaluated in both groups. 
The positivity rates were similar: a rate of 13.5% was iden-
tified in the self-collection group, and a rate of 11.0% was 
identified in the group that underwent conventional col-
lection (11.0%)  [19] . In another study conducted in 
northeastern Brazil, Holanda et al.  [17] compared the 
HPV positivity rate (hybrid capture) in a group compris-
ing 878 women who underwent collection in two stages. 
In the first stage, women self-collected vaginal material 
using a brush in their own homes. One week later, an-
other sample was obtained, and the collection was now 
performed by a gynecologist using a brush and spatula. 
Surprisingly, the high-risk HPV positivity rate was higher 
in the samples collected by the women themselves (33.9 
vs. 28.6%)  [17] . Although studies on self-collection for 
screening of cervical cancer are scarce in Brazil, one can 
still say that the technique seems to be very promising in 
a real-life context, in which many women may not even 
have access to the health care system for Pap testing.
 Unlike other studies that have adopted specific devices 
to perform self-collection, we chose to use materials that 
would be easily found in public health facilities or even in 
pharmacies, such as a syringe, a urethral probe, and sa-
line. The initial proposal was to offer women – and even 
potentially make available to health services – a simple 
and inexpensive alternative to self-collection that is not 
dependent on commercial devices specifically designed 
for that purpose, such as brushes or irrigators. This, in 
theory, could improve the outreach to women who do not 
participate in cervical cancer screening for fear or embar-
rassment, since performing self-collection with material 
that is inexpensive and readily available in the commu-
nity is feasible.
 The results obtained in this study show that self-col-
lection is well accepted among women, with self-collec-
tion involving inserting a syringe filled with saline and a 
urethral tube deeply into the vagina. Most women did not 
report having any problem with understanding or carry-
ing out the self-collection procedure; most of them re-
ported that it was actually an easy method to perform. 
Data from the literature corroborate these findings. Jones 
et al.  [20] , who conducted a study on 197 women using a 
device for vaginal lavage for self-collection, found wide 
acceptance of the method, since the majority of the wom-
en (96%) reported that the collection process was com-
fortable. However, our results may be biased, since all the 
women, at least theoretically, did not have any problem 
with conventional collection. Therefore, it has to be ex-
pected to have been highly acceptable among them.
 Nevertheless, one should note the limitations of the 
self-collection method employed in this study. The liquid 
injected into the vagina often flowed out of the vagina, 
causing some discomfort. In a few cases, there was total 
or partial loss of the cervical material, rendering it unus-
able even for laboratory analysis. Another important lim-
itation is the fact that the vial used for storage of the ma-
terial (SurePath) contained products that are harmful to 
health, such as ethanol, isopropanol, and, in very small 
amounts, methanol and formaldehyde. Household use of 
the vial could be risky and may cause health issues to 
women in the event of accidental or intentional ingestion 
of the conservation fluid, leading to severe poisoning, es-
pecially due to the intake of methanol and isopropanol. 
Thus, a hurdle that needs to be overcome is the provision 
of a vial containing a preservative solution free from 
products that are harmful to health, thus posing no risk if 
used in a domestic environment.
 When the cytological results were evaluated, self-col-
lection was expectedly in poor concordance with the re-
sults from the cytological examination of the samples ob-
tained by conventional collection. Moreover, the repre-
sentation of the transformation zone was higher in the 
cervical samples. These results are not surprising, given 
that the number of cells present in the lavage fluid was 
much lower than that present in the sample collected by 
smear, which contains more cells derived from the vagi-
na. Similar data are to be found in the literature. Nobben-
huis et al.  [4] studied 71 women who were submitted to 
vaginal self-collection by irrigation (syringe and catheter) 
followed by collection of cervical material using a brush 
by a gynecologist. The concordance of the cytological re-
sults obtained using the two forms of collection was poor, 
with an absolute concordance of 41% and a κ coefficient 
of 0.14, values that are very close to those identified in this 
study. The current study also found a poor representation 
of squamocolumnar junction cells and endocervical cells 
when collection was carried out by lavage, which did not 
come as a surprise, for the reasons previously mentioned. 
In conclusion, our results support those of previous stud-
ies which suggest that vaginal self-collection through ir-
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rigation is no applicable or useful strategy for the screen-
ing of cervical cancer by way of cytology examination.
 Regarding the analysis of accuracy for the detection of 
CIN 2+, the method that achieved the best performance 
was using the high-risk HPV test on cervical samples, a 
finding which should encourage public health authorities 
to not postpone the introduction of the test into the Uni-
fied Health System. In our study, following that proce-
dure, a cytological examination was conducted on sam-
ples also derived from the cervix. Examinations of self-
collected material showed a poorer diagnostic performance 
than those of material derived directly from the cervix. 
We observed that the molecular test conducted on sam-
ples obtained by self-collection underperformed that of 
conventional cervical cytology. Wang et al.  [21] evaluated 
396 women aged 25–65 years who performed self-collec-
tion with the aid of a device (Conical Cervical Sampler; 
Qiagen Inc.). The authors observed that the HPV test 
(careHPV) obtained by self-collection of samples pre-
sented a sensitivity of 75.0% overall and 66.7% when cells 
were preserved in liquid medium and on an FTA card, 
respectively. Nevertheless, the sensitivity rates were sig-
nificantly lower when compared with tests performed on 
cervical specimens collected by a physician (83.3%, for 
both cells preserved in liquid medium and those on FTA 
cards). In another study, Labani and Asthana  [22] dem-
onstrated that samples obtained by self-collection con-
tained much lower viral loads than those obtained by con-
ventional collection. That finding would explain the re-
sults we found in our study, where the HPV test performed 
on samples obtained by self-collection had a worse diag-
nostic performance in detecting CIN 2+ than the test con-
ducted on samples obtained directly from the cervix.
 Valdez et al.  [23] conducted a study involving more 
than 7,500 women in rural China and observed much 
higher sensitivity rates than those achieved in the current 
study using HPV testing for the diagnosis of cervical pre-
cursor lesions. According to that study, the careHPV test 
sensitivity rates for CIN 2+ detection were 82.6 and 95.8% 
when samples were collected by the women themselves 
and by the doctor, respectively. Regarding hybrid cap-
ture, the rates were 91.7 and 95.8% when samples were 
obtained by the women and by the doctor, respectively. 
Although their rates were much higher than those found 
in our study, Valdez et al.  [23] also observed that the sen-
sitivity of the HPV test was lower in samples obtained by 
self-collection.
 In summary, self-collection performed by vaginal la-
vage with a syringe and urethral probe is a method that is 
simple and well accepted by women. Still, this study 
shows that cervical cytology performed on material ob-
tained by self-collection should not be used for screening, 
given the dismal cellular sampling of endocervical cells 
and the transformation zone. Regarding HPV testing as a 
screening tool, the sensitivity of this method for detecting 
CIN 2+ in samples collected by the women themselves 
was poorer in quality when compared with the samples 
obtained directly from the cervix. Due to such limitations, 
self-collection by lavage should be utilized with caution, 
and its role in the screening of cervical cancer in Brazil 
needs to be better defined.
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